Specific fluorescent tracers. Imaging and applications for photodynamic therapy

Area of Science:

• Biomedical Sciences
• Optical Imaging
• Cancer Therapeutics

Background:

• Fluorescence imaging is crucial for understanding biological processes.
• Photodynamic therapy (PDT) utilizes photosensitizers to treat cancer.
• Meta-tetra(hydroxyphenyl)chlorin (m-THPC) is a second-generation photosensitizer used in PDT.

Purpose of the Study:

• To investigate the localization and cell death mechanisms of m-THPC in human breast cancer cells (MCF-7 and MCF-7DXR).
• To develop novel fluorescent tracers with hydrophilic groups for targeted delivery.
• To enhance fluorescence microscopy resolution using scanning near-field optical microscopy for PDT research.

Main Methods:

• Fluorescence microscopy was used to analyze m-THPC localization and cell death.
• Synthesis of new fluorescent tracers incorporating hydrophilic moieties (glucosamine ring).
• Scanning near-field optical microscopy (SNOM) was employed for high-resolution imaging.

Main Results:

• m-THPC localization and its effects on cell death mechanisms were characterized in breast cancer cell lines.
• Novel fluorescent tracers with potential for targeted delivery were synthesized.
• SNOM demonstrated improved resolution for fluorescence microscopy analysis.

Conclusions:

• This research expands the application of fluorescence in biosciences, particularly for PDT.
• The developed fluorescent tracers and advanced imaging techniques offer new possibilities for cancer treatment research.
• Enhanced understanding of m-THPC action and improved imaging capabilities can advance PDT efficacy.